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Abstract
The adult female pituitary has significantly more
lactotrophs than that of the male, while the later has a
higher percent of somatotrophs. It is clear that GH and
prolactin (PRL) gene expression and somatotroph and
lactotroph proliferation are modulated by the postpubertal
hormone environment; however, the role of the neonatal
steroid environment in this process is not known. We have
used in situ hybridization to determine the number of GH
and PRL mRNA-containing cells, as well as the level of
expression of these two hormones, in response to neonatal
and adult testosterone treatment. Female rats exposed to
testosterone during the neonatal period, adulthood or both
periods, as well as normal females and males were used.
Exposure to testosterone during the neonatal period
significantly increased the percentage of somatotrophs
(ANOVA: P<0·005) and decreased that of lactotrophs in
the adult female rat (ANOVA: P<0·001). Adult testoster-
one treatment had no significant eﬀect on the percentage
of somatotrophs. The percentage of lactotrophs was sig-
nificantly increased by adult testosterone only in those rats
also exposed to neonatal testosterone. PRL mRNA con-
centrations, as reflected by silver grains/cell, were reduced
by neonatal testosterone and increased by adult testos-
terone treatment (ANOVA: P<0·0001). Overall PRL
mRNA levels, measured by densitometry, were also
reduced by neonatal testosterone exposure, but adult
testosterone had no eﬀect (ANOVA: P<0·001). GH
mRNA levels per cell, as reflected by silver grains/cell,
were increased by adult testosterone, while neonatal
testosterone treatment had no eﬀect. Overall GH mRNA
levels per unit area, determined by densitometry measure-
ments, were increased by both neonatal and adult testos-
terone treatment, with the combination of these two
treatments resulting in adult females having levels
indistinguishable from intact males (ANOVA: P<0·003).
These results suggest that, in combination with post-
pubertal sex steroids, the neonatal gonadal steroid environ-
ment plays an important role in determining anterior
pituitary hormone synthesis and cellular composition.
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Introduction
After the onset of puberty the hormonal output of the
anterior pituitary diﬀers substantially between males
and females. While females produce and secrete larger
quantities of prolactin (PRL), the male pituitary synthe-
sizes significantly more growth hormone (GH) (Birge et al.
1967, Döhler & Wuttke 1974, Jansson et al. 1985, Tong
et al. 1989, Gabriel et al. 1992, González-Parra et al.
1996a). Postpubertal sex steroids are important in gener-
ating this phenomenon, but the neonatal gonadal steroid
environment is also implicated (Jansson et al. 1985, Jansson
& Frohman 1987a). However, the role of neonatal steroids
is less well understood. Development of the neuroendo-
crine hypothalamus, including those neurons involved in
GH or PRL control, is aﬀected by the neonatal steroid
environment (Matsumoto & Arai 1976, Matsumoto 1991,
Chowen et al. 1992, 1993, Murray & Gilles 1993,
Reznikov & Nosenko 1995) and various hypothalamic
neuropeptides are also implicated in somatotroph and
lactotroph development (Chatelain et al. 1979, Billestrup
et al. 1986, Hoeﬄer & Frawley 1987, Cella et al. 1994,
Van Bael et al. 1998, Dean & Porter 1999). Hence,
anterior pituitary development and control could be influ-
enced indirectly by the neonatal steroid environment via
modulation of its hypothalamic input, or neonatal steroids
could act directly at the level of the pituitary.
In the postpubertal animal, the anterior pituitary of the
female has more lactotrophs, while that of the male has
a higher percentage of somatotrophs (Takahashi &
Kawashima 1982, Ho et al. 1986, 1988, Hoeﬄer &
Frawley 1986, González-Parra et al. 1998). These two cell
types are derived from a common precursor and require
the presence of the transcription factor Pit-1 for their
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development and hormone expression (Li et al. 1991). This
transcription factor is diﬀerentially expressed in lactotrophs
and somatotrophs both in vivo and in vitro (González-Parra
et al. 1996a, Chowen et al. 1998) and its regulation by sex
steroids and other factors is cell-type specific and highly
correlated to changes in PRL and GH gene expression
(González-Parra et al. 1996a, Chowen et al. 1998). Modu-
lation of the adult gonadal steroid environment can shift
the percentage of GH- or PRL-containing cells, or in-
crease the number of mammosomatotrophs, so that the
female anterior pituitary more closely resembles that of the
male, or vice versa (Boockfor et al. 1985, Ho et al. 1988,
Goth et al. 1996, González-Parra et al. 1998). However,
only a relatively small percentage of these cells appear to
have the ability to change their hormone production,
suggesting that the phenotype of some anterior pituitary
cells may be determined during an earlier stage of
development and be unchangeable. Indeed, we have
previously shown that a larger change in the percentage of
both lactotrophs and somatotrophs occurs in the male rat
when the neonatal steroid environment is modulated
(González-Parra et al. 1998).
The in vivo synthesis and secretion per individual
somatotroph or lactotroph also diﬀers between adult
female and male rats, with males producing higher levels
of GH and females of PRL (Ho et al. 1986, 1988, Hoeﬄer
& Frawley 1986, González-Parra et al. 1996a). Whether
this is due solely to diﬀerences in the postpubertal steroid
environment is controversial; however, when exposed
in vitro to the same sex steroid environment, lactotrophs
and somatotrophs of male and female animals have similar
levels of PRL and GH mRNA (González-Parra et al.
1998). This suggests that the adult sex steroid environment
may be more involved in modulating the level of hormone
production, with the neonatal steroid environment play-
ing a more important role in determining the cellular
composition of the anterior pituitary.
The aims of this study were as follows. (1) To evaluate
the eﬀects of the neonatal steroid environment on GH and
PRL mRNA expression in the adult female pituitary. (2)
To determine if the neonatal sex steroid environment
modulates the number of lactotrophs and somatotrophs in
the adult female anterior pituitary. (3) To examine
whether exposure to testosterone during neonatal life
influences the ability of the pituitary to modulate these cell
populations in response to adult testosterone treatment. (4)
To correlate the changes in the number of lactotrophs and
somatotrophs with changes in GH and PRL mRNA
concentrations.
Materials and Methods
Animals and housing
Wistar rats from our in-house breeding colony were
housed with a ratio of 12 h light:12 h darkness, with lights
on at 0600 h. They were given free access to rat chow and
tap water.
Experimental design
To assess the eﬀects of sex steroids on GH and PRL
mRNA levels and the number of lactotrophs and
somatotrophs, female rats were treated with testosterone
during the neonatal period (day of birth), adulthood
(60 days) or both periods. Neonatal steroid treatment
consisted of an s.c. injection of 250 µg testosterone, a dose
shown to masculinize GH secretory patterns ( Jansson &
Frohman 1987a), dissolved in 100 µl sesame oil. The
neonatal control group received an injection of 100 µl
sesame oil. The neonatal animals that received sesame oil
are referred to as FNO (female neonatal oil) and those
receiving sesame oil containing testosterone as FNT
(female neonatal testosterone). The intact male group (IM)
also received an injection of sesame oil.
At 60 days of age, the animals received the second
steroid treatment. Each of the neonatal treatment groups
was randomly divided into two groups, one that received
an empty Silastic capsule and the other a Silastic capsule
containing crystalline testosterone. These capsules were
designed to deliver adult male levels of circulating testos-
terone and their preparation has been described previously
(Steiner et al. 1982). These treatments resulted in the
following experimental groups: FNOAO (female, neo-
natal oil, adult oil), FNTAO (female, neonatal testoster-
one, adult oil), FNOAT (female, neonatal oil, adult
testosterone), FNTAT (female, neonatal testosterone,
adult testosterone) and IM (intact male). To minimize
fluctuation in the results for cyclic females, in the group
that had estrous cycles (FNOAO) only those females
exhibiting at least two consecutive 4-day cycles were used
and were killed on the morning of estrus. This day was
chosen since females treated with testosterone are in a state
similar to constant estrus. All animals were killed between
75 and 77 days of age between 0900 and 1100 h.
To determine overall mRNA levels for each peptide,
in situ hybridization using a radioactive probe was per-
formed. To determine the number of either lactotrophs
or somatotrophs per unit area, riboprobes labeled with
digoxigenin were employed.
Tissue preparation for in situ hybridization
On the day on which they were killed, animals were
asphyxiated with carbon dioxide and immediately
decapitated. The pituitaries were removed, rapidly frozen
on dry ice, and stored intact at 80 C until processed for
in situ hybridization histochemistry. Trunk blood was
collected at the time of decapitation and separated by
centrifugation. The serum was stored at 20 C until
assayed for testosterone.
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Before cutting, pituitaries were allowed to equilibrate
in the cryostat (17 C) and embedded in OCT
(Tissue-Tek, Elkhart, IN, USA). Sections (12 µm) were
thaw-mounted onto poly--lysine-coated slides. Tissue
slices were stored at 80 C in airtight boxes until
hybridization histochemistry was performed.
Riboprobe preparation
The original plasmid, pBR322-GH1, contains a 790 bp
insert of a rat GH cDNA clone (Harpold et al. 1978,
Dobner et al. 1981). A 451 bp Ava I/Pvu II fragment of
this clone was further subcloned into a pGem3Z vector.
This plasmid was kindly provided by P M Martha Jr,
Baustate Medical Center, Springfield, MA, USA. The
plasmids, SP65–1 and SP65–2, each containing a 780 bp
fragment of the PRL cDNA, but in opposite directions,
were used to transcribe antisense and sense PRL probes
respectively. These plasmids were provided by R A
Maurer (Gubbins et al. 1979, 1980).
In vitro transcription with S35-UTP for radioactive
probes was carried out as previously described (Chowen
et al. 1991) and resulted in a specific activity of approxi-
mately 1·3108 d.p.m./µg for both GH and PRL.
Transcription of digoxigenin probes was carried out
according to the manufacturer’s instructions (Boehringer
Mannheim, Mannheim, Germany). All probes were
hydrolyzed to approximately 150 bases in 100 mM
bicarbonate (pH 10·2) at 60 C.
In situ hybridization
After fixation in 4% paraformaldehyde, tissue sections
were pretreated with 0·25% acetic anhydride in 0·1 M
triethanolamine (pH 8·0) for 10 min. The slides were
rinsed in 2SSC (300 mM NaCl and 30 mM Na citrate)
and blotted. The probes were applied in 60 µl hybridiz-
ation buﬀer at saturating concentrations. The slides were
then covered with a strip of parafilm, sealed with rubber
cement, and incubated overnight in moist chambers at
45 C. The following day, the parafilm coverslips were
peeled oﬀ and the slides rinsed in 4SSC. After RNAase
treatment and a series of washes in SSC of increasing
stringency, the slides were dehydrated in alcohol and
air-dried.
Slides were dipped in Kodak NTB-2 emulsion
(Eastman Kodak, Rochester, NY, USA) that had been
diluted 1:1 with 600 mM ammonium acetate and heated
to 45 C in a water bath. They were allowed to air-dry for
15 min, then further dried in a moist chamber at room
temperature for 1 h. Slides were placed in light-tight boxes
containing desiccant and exposed for 4 days (PRL) or
5 days (GH) at 4 C. For all assays, slides were developed
and counterstained with cresyl violet, and coverslips were
then applied. (For more detail see Chowen et al. 1991.)
In situ hybridization assays with digoxigenin probes were
performed equal to that for radioactive probes through the
final wash in 0·1SSC; thereafter, instead of dehydrating
the slides, they were incubated with 2SSC containing
0·5% Triton X-100 and 2% normal sheep serum for 1 h at
room temperature. The slides were then washed in buﬀer
1 (100 mM Tris–HCl, pH 7·5, 150 mM NaCl) twice
(10 min each) and incubated overnight at 4 C with anti-
digoxigenin antibody conjugated to alkaline phosphatase
(Boehringer Mannheim; 1:1000 in buﬀer 1 containing 1%
normal sheep serum and 0·4% Triton X-100). The slides
were washed once in buﬀer 1 (10 min) and then buﬀer 2
(100 mM Tris–HCl, pH 9·5, 100 mM NaCl, 50 mM
MgCl2) twice for 10 min each. They were then incubated
in 338 µg/ml nitroblue tetrazolium–chloride, 175 µg/ml
5-bromo-4-chloro-3-indolyl-phosphate (Boehringer
Mannheim) and 240 µg/ml levamisole (Sigma Chemical
Co., St Louis, MO, USA) in buﬀer 2 in a light-tight box
overnight at room temperature. The following day the
reaction was stopped in 10 mM Tris–HCl, pH 8·0 and
1 mM EDTA. The slides were rapidly dehydrated and
coverslipped.
Control experiments
Control experiments, including employment of sense
riboprobes and saturation curves, were performed for the
riboprobes to verify their specificity and to determine the
optimum concentration of probe for the quantitative
assays. These results have been published previously
(González-Parra et al. 1996a,b). As expected, specific
binding of both riboprobes was seen over the anterior
pituitary and not the posterior pituitary.
Image analysis system
Eight tissue sections throughout the entire anterior
pituitary from each animal were included in the analysis of
mRNA concentration. Slides selected for analysis were
assigned a random three-letter code and analyzed in
alphabetical, hence random, order by an operator unaware
of the experimental group to which the animal belonged.
The automated image-processing system consists of a Pixel
Grabber video acquisition board (Perceptics Corp.,
Knoxville, TN, USA) attached to a Macintosh IIci com-
puter. The software, Image, supplied by the National
Institutes of Health, was used for densitometric analysis of
tissue sections and Grains, written by D K Clifton at the
University of Washington, Seattle, WA, USA, was used to
determine grains/cell. Video images were obtained by a
Sony camera (Sony Corporation, Japan) attached to a Zeiss
Axioplan Photomicroscope.
To determine the relative level of specific mRNA per
cell, the number of silver grains/individual cell was
analyzed in approximately 100 cells per animal. A back-
ground reading was taken with each individual cell
analysis and automatically subtracted. One diﬃculty with
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this analysis was the close proximity of the anterior
pituitary cells, which limits the availability of some cells for
analysis. Only cells that could be individually isolated were
analyzed with this system, which could bias the data. This
caveat should be taken into consideration.
For densitometric analysis, darkfield illumination with a
20 magnification objective was used. In each tissue
section, approximately ten diﬀerent fields were selected
and analyzed (approximately 80 readings/animal). Each
field included only the anterior pituitary and had a clear
signal free of artifacts. Background readings were taken in
each section by measuring the non-specific signal over the
posterior pituitary. The specific signal in each section was
then calculated by subtracting the mean density obtained
in the posterior pituitary from that obtained in the anterior
pituitary. The non-specific signal over the posterior
pituitary did not diﬀer significantly between the exper-
imental groups or within a group and did not exceed 10%
of the specific signal.
The relationship between increasing concentrations of
radioactivity and densitometry readings in this assay system
has been reported previously, as well as the relationship
between the signals received with in situ hybridization and
protection assays (Chowen et al. 1991). Furthermore, it
was verified that with increasing amounts of radioactive
probe applied to the sections an increase in signal was
detected with all probes until the available binding sites
were saturated. All assays were run at saturating concen-
trations. Therefore, the densitometry readings reported
reflect relative levels of specific mRNA signal and are
reported as densitometry units.
The number of GH mRNA- or PRL mRNA-
containing cells was determined by analyzing six tissue
sections/animal dispersed throughout the entire anterior
pituitary. Using a 100 objective, the operator counted
the number of positive cells in 12 diﬀerent fields in each
section (12 fields/section, 6 tissue sections or 72 fields per
pituitary). A cell was determined to be positive if the
intensity of its labeling was at least 5% higher than the
mean background reading taken over cells of the posterior
pituitary. The mean number of unlabeled cells per area
was also determined so that the percentage of labeled cells
could be determined.
Serum testosterone assay
Trunk blood was collected when the animals were killed
and allowed to clot. It was then centrifuged and the serum
separated and stored at 20 C until assayed. Using an
antibody and standard supplied by the WHO Matched
Reagent programme, testosterone levels were measured
by RIA, as previously described (Matsumoto et al. 1983).
The sensitivity of this assay was 0·17 nmol/l in a 100 µl
sample. The intra- and inter-assay coeﬃcients of variations
were 4·0% and 10% respectively.
Statistical analysis
For both GH and PRL, approximately 100 cells/animal
were analyzed to obtain the mean grains/cell for each
animal. The mean number of densitometry units for each
animal was determined from the analysis of approximately
80 fields of view per animal. The mean number of cells per
unit area was calculated from the analysis of approximately
72 fields per animal. The mean for each animal was then
used to determine the means... for each experimen-
tal group, with the n in all statistical analyses referring to
the number of animals in the group (n=5 per group). To
determine whether there was an interaction between
neonatal steroid treatment and adult steroid treatment on
either cell number or overall mRNA levels, a two-way
analysis of variance (ANOVA) was performed. A one-way
ANOVA followed by a Scheﬀé F test was performed to
determine whether diﬀerences between the various groups
existed. The significance level was chosen as P<0·05.
Results
Number of GH mRNA-containing cells
Figure 1 is a representative section through the anterior
pituitary of a normal female (Fig. 1A) and a female treated
with testosterone both as a neonate and adult (Fig. 1B).
The darkly labeled cells represent those that are GH
mRNA positive. The number of labeled cells and non-
labeled cells per field was assessed. The total number of
cells per view was not significantly diﬀerent in any of the
experimental groups.
The mean percentage of GH mRNA-positive cells per
unit area was significantly lower in female rats as compared
with males (Fig. 1C; ANOVA: P<0·005). Those animals
exposed to testosterone during the neonatal period had a
significantly higher percentage of GH mRNA-containing
cells compared with those not exposed to testosterone
during this time-period (FNTAO vs FNOAO). Adult
testosterone treatment had no significant eﬀect.
Number of PRL mRNA-containing cells
Figure 2A is a section through the anterior pituitary of a
normal female and Fig. 2B that of a female treated with
testosterone both as a neonate and as an adult. The darkly
labeled cells represent those that are PRL mRNA positive.
The number of labeled cells and nonlabeled cells per field
was assessed. The total number of cells per view was not
significantly diﬀerent in any of the experimental groups.
Normal female rats had significantly more PRL
mRNA-containing cells per unit area when compared
with males (Fig. 2C; ANOVA: P<0·001). Exposure to
testosterone during the neonatal period significantly
decreased the number of PRL mRNA-containing cells
(FNTAO vs FNOAO and FNTAT vs FNOAT). Adult
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steroid treatment increased the percentage of PRL
mRNA-containing cells, but this was only significant in
those animals that were also exposed to testosterone
during the neonatal period (FNTAO vs FNTAT).
GH mRNA levels
GH mRNA levels per individual cell, as represented by
grains/cell, were significantly higher in intact males com-
pared with normal estrous females (Fig. 3A). Neonatal
testosterone treatment did not significantly aﬀect GH
mRNA levels per individual cell. Adult testosterone
treatment increased GH mRNA levels and this response
was not aﬀected by neonatal testosterone treatment.
The overall GH mRNA density level was significantly
lower in normal females compared with males (Fig. 3B).
Both neonatal and adult testosterone treatments signifi-
cantly increased GH mRNA density levels (ANOVA:
P<0·003). Furthermore, exposure to testosterone during
the neonatal period significantly increased the response
to adult testosterone treatment (two-way ANOVA:
P<0·01). The eﬀect of neonatal and adult testosterone was
additive, resulting in females exposed to testosterone
during both periods having GH mRNA levels similar to
those found in intact males.
In Fig. 4 the diﬀerence in GH mRNA signal density
between a normal female (Fig. 4A) and a female treated
with testosterone during both the neonatal and adult
period (Fig. 4B) can be appreciated.
PRL mRNA levels
Mean PRL mRNA concentration per cell was sig-
nificantly higher in normal females compared with
males (Fig. 5A; ANOVA: P<0·0001). Neonatal testos-
terone treatment significantly reduced PRL mRNA
Figure 1 Brightfield photomicrographs of sections through the anterior pituitaries of a
normal adult female rat (A) and a female treated with testosterone on the day of birth and
during adulthood (B) on which in situ hybridization to detect GH mRNA was performed.
The darkly stained cell bodies represent GH mRNA-containing cells. (C) Mean percentage
(S.E.M.) of GH mRNA-containing cells/unit area in the anterior pituitary. FNOAO=normal
female, FNOAT=female receiving testosterone during adulthood, FNTAO=female receiving
testosterone as a neonate, FNTAT=female receiving testosterone both as a neonate and an
adult, IM= intact male. *P<0·005: ANOVA; n=5 in each group.
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concentration/cell in the adult female rat. Adult testoster-
one had no eﬀect on female rats not exposed to neonatal
testosterone; however, it significantly increased PRL
mRNA levels in those females treated with neonatal
testosterone. Hence, the neonatal sex steroid environment
modulated the response of lactotrophs in the adult animal
to testosterone (two-way ANOVA: P<0·0001).
Overall PRL mRNA density levels were significantly
higher in females compared with males (Fig. 5B,
ANOVA: P<0·001). Treatment of female animals with
testosterone during the neonatal period resulted in a
significant reduction in overall PRL mRNA levels, while
adult testosterone treatment had no significant eﬀect.
In Fig. 6 the diﬀerence in PRL mRNA signal density
between a normal female (Fig. 6A) and a male (Fig. 6B)
can be appreciated.
Testosterone levels
The testosterone levels are shown in Table 1. The serum
testosterone levels of the intact male and female rats were
in the normal physiological range. Neonatal treatment
with testosterone did not aﬀect adult steroid levels.
Animals treated with Silastic capsules containing testoster-
one had levels within the physiological range for intact
adult males.
Discussion
The early postnatal hormone environment can have
dramatic eﬀects on the anterior pituitary since this gland is
relatively immature at birth and continues to develop
throughout neonatal life (Smets et al. 1989, Simmons
Figure 2 Brightfield photomicrographs of sections through the anterior pituitaries of a
normal female rat (A) and a female treated with testosterone both as a neonate and an
adult (B) on which in situ hybridization to detect PRL mRNA was performed. The darkly
stained cell bodies represent PRL mRNA-containing cells. (C) Mean percentage (S.E.M.) of
PRL mRNA-containing cells/unit area in the anterior pituitary. FNOAO=normal female,
FNOAT=female receiving testosterone during adulthood, FNTAO=female receiving
testosterone as a neonate, FNTAT=female receiving testosterone as a neonate and adult,
IM= intact male. *P<0·001: ANOVA; n=5 in each group.
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1990). During adulthood, this gland remains under a
dynamic state of cellular turnover with apparently fully
diﬀerentiated cells undergoing mitotic division, with the
majority of these proliferating cells expressing either GH
or PRL (Dada et al. 1984, Carbajo-Pérez & Watanabe
1990, Oishi et al. 1993). Although there is active cellular
turnover, the phenotypic make-up of the anterior pituitary
is maintained unless the surrounding milieu is changed.
Indeed, if the gonadal steroid environment is modulated
the percentage of lactotrophs and somatotrophs can be
shifted. However, in both adult males (González-Parra
et al. 1998) and females, as shown here, the percentage of
cells capable of changing their phenotype may be limited.
The cellular composition and size of the pituitary begin
to diﬀer between the sexes after the onset of puberty when
the proliferation of anterior pituitary cells in the female
starts to exceed that in males (Takahashi & Kawashima
1982, Hoeﬄer & Frawley 1987, Carbajo-Pérez &
Watanabe 1990, Oishi et al. 1993). Postpubertal females
have larger anterior pituitaries (Hoeﬄer & Frawley 1987,
Carbajo-Pérez & Watanabe 1990) with a higher percent-
age of lactotrophs, while pituitaries of males contain
a higher percentage of somatotrophs (Takahashi &
Kawashima 1982, Ho et al. 1986, 1988, Hoeﬄer &
Frawley 1986). Our results are in agreement with these
findings and the proportion of each cell type reported here
is similar to that found previously by using protein content
or secretion for identification of cell type (Takahashi &
Kawashima 1982, Ho et al. 1986, 1988, Hoeﬄer &
Frawley 1986, Goth et al. 1996). Hence, in situ hybrid-
ization is at least as sensitive as these other techniques in
detecting lactotrophs and somatotrophs and the diﬀerences
reported here are not due to our inability to detect cells
producing low levels of the hormone in question.
Testosterone treatment during only the adult period
increased the number of lactotrophs in female rats by less
than 5% and the overall percentage of somatotrophs by
approximately 10%. These changes are similar to those
reported previously in males (Ho et al. 1988, González-
Parra et al. 1998) and suggest that the percentage of cells in
the normal adult female pituitary that can be recruited to
shift between GH or PRL expression is also limited. In
contrast, adult testosterone treatment increased lactotrophs
by approximately 30% in females exposed to testosterone
neonatally. Hence, the neonatal environment may be
important for determining the later responsiveness of these
cells to changes in the steroid environment.
Modulation of the neonatal steroid environment has a
dramatic eﬀect on the cellular composition of the anterior
pituitary. Exposure to testosterone during only the neo-
natal period reduced the number of lactotrophs by over
40% and increased the number of somatotrophs by
approximately 20%. This resulted in the pituitary com-
position being more similar to that of an adult male and
further demonstrates that the neonatal environment is
involved in determining the cellular composition of the
anterior pituitary gland.
Hypothalamic factors are undoubtedly important for
development of the anterior pituitary (Chatelain et al.
1979, Hoeﬄer & Frawley 1987, Smets et al. 1989, Cella
et al. 1994, Van Bael et al. 1998, Dean & Porter 1999) and
whether the observed eﬀects of sex steroids are mediated
directly on the pituitary or via the hypothalamus remains
to be determined. Expression of the transcription factor
Pit-1 correlates temporally to when the developing
pituitary and hypothalamus become physically connected
and production of Pit-1 protein is followed by GH and
PRL expression (Smets et al. 1989, Dollé et al. 1990). Pit-1
is involved in the expression of the GH-releasing hormone
(GHRH) receptor in the pituitary (Lin et al. 1992) and
GHRH stimulates somatotroph proliferation in vitro
(Billestrup et al. 1986). Transient lack of GHRH during
development causes a decrease in GH production in
Figure 3 Comparison of relative mean concentrations of GH
mRNA in the anterior pituitary of normal females (FNOAO),
females receiving testosterone as adults (FNOAT), females
receiving testosterone during neonatal life (FNTAO), females
receiving testosterone both as neonates and adults (FNTAT) and
intact males (IM). n=5 in each group. (A) GH mRNA
concentrations/cell, as determined by grains/cell, *P<0·0001:
ANOVA. (B) GH mRNA concentrations per unit area as
determined by densitometry, *P<0·003: ANOVA.
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the adult, as well as a reduced response to GHRH (Cella
et al. 1994). Furthermore, when hypothalamic input is
lacking, more lactotrophs develop (Shiino et al. 1977).
These results could suggest that GHRH stimulates
somatotroph proliferation and may be important for stop-
ping cell development at this level, impeding the pro-
gression to lactotrophs. Other factors, such as estrogens,
may function to shift the development towards lactotrophs.
Indeed, activation of the estrogen receptor in conjunction
with Pit-1 is necessary for lactotroph development
(Simmons et al. 1990) and estrogen decreases GHRH
receptor mRNA levels in the pituitary (Lam et al. 1996),
which could decrease GH expression. In contrast, expres-
sion of GHRH is increased by both neonatal and post-
pubertal testosterone (Zeitler et al. 1992, Chowen et al.
1993) and is sexually dimorphic during the neonatal period
(Argente et al. 1991) when the anterior pituitary is in
a highly active phase of proliferation (Carbajo-Pérez
& Watanabe 1990). Hence higher GHRH levels in
male animals (Jansson et al. 1985, Argente et al. 1991)
Figure 4 Darkfield photomicrograph of a section through the pituitary of an estrous female
(A) and a female treated with testosterone on the day of birth and during adulthood (B) on
which in situ hybridization was performed to detect GH mRNA. The white grain clusters
represent GH mRNA-positive cells.
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may induce the development of a higher percentage of
somatotrophs and fewer lactotrophs.
Both androgen and estrogen receptors are found in
the developing and adult pituitary gland (Keefer &
Holdeegger 1985, Babichev et al. 1990, Burgess & Handa
1993, Scully et al. 1997, Wilson et al. 1998) and both classes
of steroids may be involved in determining the cellular
composition of the anterior pituitary. Disruption of the
estrogen receptor- results in a decrease in lactotroph
number and PRL production, but an increase in GH
production (Scully et al. 1997), suggesting that the eﬀects
on lactotrophs may be via the estrogen receptor with little
or no estrogen eﬀect on somatotroph number. Neonatal
castration of male rats reduces androgen receptors in the
adult pituitary (Babichev et al. 1990), which may be due to
a decrease in the number of cells expressing this receptor or
the number of receptors per cell. In vitro, lactotrophs and
somatotrophs from male and female rats have similar
changes in mean GH, PRL and Pit-1 mRNA levels per
cell in response to sex steroids (Chowen et al. 1998),
suggesting that individual cells from the two sexes have a
similar responsiveness to gonadal steroids and, hence, may
express similar levels of the receptors for these steroids.
The number of GH-expressing cells/area is not signifi-
cantly modified by adult testosterone treatment, but GH
mRNA levels/cell are increased and this is also reflected in
an increase in GH mRNA density levels. This increase in
GH expression/cell might augment our ability to detect
low expressing cells and explain the slight increase in the
percentage of GH mRNA-containing cells after adult
testosterone treatment and not reflect a true increase in
somatotrophs/area. Neonatal testosterone increases the
percentage of GH mRNA-containing cells/area and GH
mRNA levels/area, but has no significant eﬀect on GH
mRNA levels/cell. Hence, both neonatal and adult
testosterone treatments increase GH mRNA density, but
through diﬀerent mechanisms. In the adult animal, the
in vivo eﬀects of testosterone on GH mRNA levels per
individual cell are most likely via modulation of GHRH
and somatostatin (Chowen-Breed et al. 1989, Argente
et al. 1990, Zeitler et al. 1992), since GH gene expression
is not modulated in vitro by this steroid (González-Parra
et al. 1996b, Chowen et al. 1998).
When female rats were exposed to testosterone during
the neonatal period, PRL mRNA levels/unit area, grains/
cell and the percentage of lactotrophs decreased signifi-
cantly. Therefore, neonatal exposure to testosterone
decreases both the number of PRL-producing cells and
their level of synthesis. Adult testosterone treatment
stimulates the percentage of lactotrophs and PRL mRNA
levels/cell, but only in animals exposed to neonatal
testosterone. In normal females, adult testosterone treat-
ment had no significant eﬀect on either the number
of lactotrophs or PRL mRNA levels. This result was
unexpected since testosterone, via aromatization to
estradiol and acting at the level of the pituitary, stimulates
PRL mRNA levels (Shull et al. 1987, Waterman et al.
1988, Chowen et al. 1998, González-Parra et al. 1996b).
Estrogen also stimulates the proliferation of lactotrophs
(Pérez et al. 1986, Ho et al. 1988, Ellerkmann et al. 1991).
It is possible that longer exposure to testosterone, in this
case 2 weeks, does not have the same eﬀect on lactotrophs
from female animals as does acute exposure.
The eﬀects of neonatal and adult testosterone treatment
in female animals were very similar to those observed
previously in male rats (González-Parra et al. 1998). One
striking diﬀerence was observed in overall PRL mRNA
levels. Treatment with testosterone during only the adult
period significantly increased PRL mRNA levels in males
while in the female there was no significant eﬀect. On the
other hand, neonatal testosterone significantly reduced
PRL mRNA levels in females and slightly increased them
in males. One caveat that must be taken into consider-
ation is that these females were not ovariectomized and
Figure 5 Comparison of relative mean levels of PRL mRNA in the
anterior pituitary of normal female rats (FNOAO), females
receiving testosterone as adults (FNOAT), females receiving
testosterone during neonatal life (FNTAO), females receiving
testosterone both as neonates and adults (FNTAT) and intact
males (IM). n=5 in each group. (A) PRL mRNA
concentrations/cell, as determined by grains/cell, *P<0·0001:
ANOVA. (B) PRL mRNA concentrations per unit area as
determined by densitometry, *P<0·001; ANOVA.
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secretions by the ovaries may be inhibitory to or modulate
some of these processes (Jansson & Frohman 1987b).
We have shown that both the neonatal and adult steroid
environments are important in determining GH and PRL
expression levels in the adult female rat and this is partially
due to influences on the cellular composition of the
anterior pituitary. Although it is well accepted that gonadal
Figure 6 Darkfield photomicrograph of a section through the pituitary of an estrous female
rat (A) and a female rat treated with testosterone during the neonatal period (B) on which
in situ hybridization to detect PRL mRNA was performed. The white grain clusters
represent PRL mRNA-positive cells.
Table 1 Mean levels of serum tesotsterone (nmol/l). Values are
meansS.E.M.
FNOAO FNOAT FNTAO FNTAT IM
0·80·09 10·00·6 1·40·1 10·60·6 10·32·7
See Experimental design for explanation of the various gropus
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steroids can modulate the number of somatotrophs and
lactotrophs in the anterior pituitary of the adult rat, we
suggest that the extent of this phenomenon may be limited
and the final percentage of a specific cell type is more
dependent on the neonatal steroid environment to which
the animal is exposed.
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